2nd Quarter - Report

ALERE INC. for ALERE INC.

Period 2nd Quarter 2013 Filed Jul 18, 2013 Signed by Seth Radus, VP, Government Affairs

Official filing
Firm
ALERE INC.
Client
ALERE INC.
Income
—
Expenses
$159,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

PEPFAR reauthorization

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Transportation TRA

Testing for driving under the influence of drugs.

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA-regulation of in-vitro diagnostic laboratory tets

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare competitive bidding program

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: State, Dept of (DOS); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Development of new and innovative in-vitro diagnostic tests.

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.